The Open-artery Hypothesis Revisited

Overview

Journal Tex Heart Inst J

Specialty Cardiology & Vascular Diseases

Date 2006 Oct 17

PMID 17041693

Citations 1

Authors

Alireza Zarrabi

Hossein Eftekhari

S Ward Casscells

Mohammad Madjid

Affiliations

Soon will be listed here.

Citing Articles

The Role of Antioxidants in the Therapy of Cardiovascular Diseases-A Literature Review.

Mlynarska E, Hajdys J, Czarnik W, Fularski P, Leszto K, Majchrowicz G Nutrients. 2024; 16(16).

PMID: 39203723 PMC: 11357572. DOI: 10.3390/nu16162587.

References

Gang E, Lew A, Hong M, Wang F, Siebert C, Peter T . Decreased incidence of ventricular late potentials after successful thrombolytic therapy for acute myocardial infarction. N Engl J Med. 1989; 321(11):712-6. DOI: 10.1056/NEJM198909143211104. View

Cucherat M, Bonnefoy E, Tremeau G . Primary angioplasty versus intravenous thrombolysis for acute myocardial infarction. Cochrane Database Syst Rev. 2003; (3):CD001560. DOI: 10.1002/14651858.CD001560. View

Volpi A, Cavalli A, Santoro E, Tognoni G . Incidence and prognosis of secondary ventricular fibrillation in acute myocardial infarction. Evidence for a protective effect of thrombolytic therapy. GISSI Investigators. Circulation. 1990; 82(4):1279-88. DOI: 10.1161/01.cir.82.4.1279. View

Puma J, Sketch Jr M, Thompson T, Simes R, Morris D, White H . Support for the open-artery hypothesis in survivors of acute myocardial infarction: analysis of 11,228 patients treated with thrombolytic therapy. Am J Cardiol. 1999; 83(4):482-7. DOI: 10.1016/s0002-9149(98)00899-6. View

Keeley E, Boura J, Grines C . Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003; 361(9351):13-20. DOI: 10.1016/S0140-6736(03)12113-7. View

. GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. Lancet. 1990; 336(8707):65-71. View

White H, Cross D, Elliott J, Norris R, Yee T . Long-term prognostic importance of patency of the infarct-related coronary artery after thrombolytic therapy for acute myocardial infarction. Circulation. 1994; 89(1):61-7. DOI: 10.1161/01.cir.89.1.61. View

Fletcher A, ALKJAERSIG N, SMYRNIOTIS F, Sherry S . The treatment of patients suffering from early myocardial infarction with massive and prolonged streptokinase therapy. Trans Assoc Am Physicians. 1958; 71:287-96. View

Steg P, Thuaire C, Himbert D, Carrie D, Champagne S, Coisne D . DECOPI (DEsobstruction COronaire en Post-Infarctus): a randomized multi-centre trial of occluded artery angioplasty after acute myocardial infarction. Eur Heart J. 2004; 25(24):2187-94. DOI: 10.1016/j.ehj.2004.10.019. View

10.

Turakhia M, Murphy S, Pinto T, Antman E, Giugliano R, Cannon C . Association of platelet count with residual thrombus in the myocardial infarct-related coronary artery among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarction. Am J Cardiol. 2004; 94(11):1406-10. DOI: 10.1016/j.amjcard.2004.08.015. View

11.

Miyamoto S, Fujita M, Sasayama S . Bidirectional function of coronary collateral channels in humans. Int J Cardiol. 2000; 75(2-3):249-52. DOI: 10.1016/s0167-5273(00)00313-2. View

12.

. Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial. AIMS Trial Study Group. Lancet. 1988; 1(8585):545-9. View

13.

Marino P, Zanolla L, Zardini P . Effect of streptokinase on left ventricular modeling and function after myocardial infarction: the GISSI (Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico) Trial. J Am Coll Cardiol. 1989; 14(5):1149-58. DOI: 10.1016/0735-1097(89)90409-9. View

14.

. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med. 1997; 336(23):1621-8. DOI: 10.1056/NEJM199706053362301. View

15.

Rentrop K . Restoration of anterograde flow in acute myocardial infarction: the first 15 years. J Am Coll Cardiol. 1995; 25(7 Suppl):1S-2S. DOI: 10.1016/0735-1097(95)00143-r. View

16.

White H, Norris R, Brown M, Brandt P, Whitlock R, Wild C . Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation. 1987; 76(1):44-51. DOI: 10.1161/01.cir.76.1.44. View

17.

Nicolau J, Nogueira P, Pinto M, Serrano Jr C, Garzon S . Early infarct artery collateral flow does not improve long-term survival following thrombolytic therapy for acute myocardial infarction. Am J Cardiol. 1999; 83(1):21-6. DOI: 10.1016/s0002-9149(98)00776-0. View

18.

Olivari Z, Rubartelli P, Piscione F, Ettori F, Fontanelli A, Salemme L . Immediate results and one-year clinical outcome after percutaneous coronary interventions in chronic total occlusions: data from a multicenter, prospective, observational study (TOAST-GISE). J Am Coll Cardiol. 2003; 41(10):1672-8. DOI: 10.1016/s0735-1097(03)00312-7. View

19.

Hirayama A, Adachi T, Asada S, Mishima M, Nanto S, Kusuoka H . Late reperfusion for acute myocardial infarction limits the dilatation of left ventricle without the reduction of infarct size. Circulation. 1993; 88(6):2565-74. DOI: 10.1161/01.cir.88.6.2565. View

20.

Lavie C, OKeefe Jr J, Chesebro J, Clements I, Gibbons R . Prevention of late ventricular dilatation after acute myocardial infarction by successful thrombolytic reperfusion. Am J Cardiol. 1990; 66(1):31-6. DOI: 10.1016/0002-9149(90)90731-f. View